Literature DB >> 21369667

Do the effects of APOE-ε4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging.

B Brown1, M H Huang, A Karlamangla, T Seeman, D Kado.   

Abstract

OBJECTIVES: To investigate whether gene nutrient interactions influence the risk of cognitive dysfunction among older persons.
DESIGN: We performed a cross-sectional and longitudinal study of 499 adults aged 70-79 years from the Mac Arthur Study of Successful Aging to determine the effect of apolipoprotein E (APOE) in conjunction with plasma levels of homocysteine and of the related B vitamins on multiple domains of cognitive function and cognitive decline.
RESULTS: The APOE-ε4 allele, high homocysteine, low folate, and low vitamin B6 levels were each associated with worse baseline cognitive function, and all but B6 and B12 were associated with seven year cognitive decline. There was no interaction between APOE-ε4, and homocysteine, folate, B6, or B12 in predicting baseline cognitive function (p-values: 0.12-0.94) or longitudinal decline (p-values: 0.52-0.91). Of five cognitive subtests, there was a significant interaction between the ε4 allele, low B6, and decline in correct naming response items (p=0.04).
CONCLUSION: B vitamin status does not influence the risk of overall cognitive dysfunction in ε4 allele affected older adults.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369667     DOI: 10.1007/s12603-010-0277-5

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  41 in total

1.  Cognitive performance in a high-functioning community-dwelling elderly population.

Authors:  S K Inouye; M S Albert; R Mohs; K Sun; L F Berkman
Journal:  J Gerontol       Date:  1993-07

2.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

3.  Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging.

Authors:  Deborah M Kado; Alexander Bucur; Jacob Selhub; John W Rowe; Teresa Seeman
Journal:  Am J Med       Date:  2002-11       Impact factor: 4.965

4.  Functional vitamin B(12) deficiency and Alzheimer disease.

Authors:  A McCaddon; B Regland; P Hudson; G Davies
Journal:  Neurology       Date:  2002-05-14       Impact factor: 9.910

5.  Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease.

Authors:  Guido Anello; Rosa-Maria Guéant-Rodríguez; Paolo Bosco; Jean-Louis Guéant; Antonino Romano; Bernard Namour; Rosario Spada; Filippo Caraci; Gregory Pourié; Jean-Luc Daval; Raffaele Ferri
Journal:  Neuroreport       Date:  2004-04-09       Impact factor: 1.837

6.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

7.  Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older.

Authors:  David Bunce; Miia Kivipelto; Ake Wahlin
Journal:  Neuropsychology       Date:  2004-04       Impact factor: 3.295

8.  Total serum homocysteine in senile dementia of Alzheimer type.

Authors:  A McCaddon; G Davies; P Hudson; S Tandy; H Cattell
Journal:  Int J Geriatr Psychiatry       Date:  1998-04       Impact factor: 3.485

9.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

Authors:  Christine M Albert; Nancy R Cook; J Michael Gaziano; Elaine Zaharris; Jean MacFadyen; Eleanor Danielson; Julie E Buring; JoAnn E Manson
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

10.  Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study.

Authors:  Miia Kivipelto; Suvi Rovio; Tiia Ngandu; Ingemar Kåreholt; Marjo Eskelinen; Bengt Winblad; Vladimir Hachinski; Angel Cedazo-Minguez; Hilkka Soininen; Jaakko Tuomilehto; Aulikki Nissinen
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

View more
  3 in total

1.  Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort.

Authors:  I Blasko; M Hinterberger; G Kemmler; S Jungwirth; W Krampla; T Leitha; K Heinz Tragl; P Fischer
Journal:  J Nutr Health Aging       Date:  2012-08       Impact factor: 4.075

Review 2.  Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing.

Authors:  Kirsty Porter; Leane Hoey; Catherine F Hughes; Mary Ward; Helene McNulty
Journal:  Nutrients       Date:  2016-11-16       Impact factor: 5.717

3.  Combined homocysteine and apoE rs429358 and rs7412 polymorphism in association with serum lipid levels and cognition in Chinese community-dwelling older adults.

Authors:  Chunxiu Wang; Xunming Ji; Zhe Tang; Zhongying Zhang; Xiang Gu; Xianghua Fang
Journal:  BMC Psychiatry       Date:  2022-03-29       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.